Skip to main content
. 2015 Apr 9;8:775–781. doi: 10.2147/OTT.S81022

Figure 2.

Figure 2

The time of PFS for the relapse and refractory MM patients treated with arsenic trioxide, ascorbic acid, ifosfamide, and prednisone.

Abbreviations: MM, multiple myeloma; PFS, progression-free survival.